Local Clinical Trial Waiver for Selected Drugs: A Double-Edged Sword
27
Dec
Local Clinical Trial Waiver for Selected Drugs: A Double-Edged Sword Sub: Sci Sec: Health Why in News The Central Licensing Authority (CLA) recently allowed a local clinical trial waiver for five categories of new drugs sourced from six countries under Rule 101 of the New Drugs and Clinical Trials Rules (NDCTR), 2019. This […]